Arthneeti

Elantas Beck India Share Price & Earnings Call Analysis

₹12,756.00-2.47% today
Market cap
₹10,113 Cr
P/E
54.12
ROE
15.73%
PEG
2.99
Price to sales
10.25
Debt to equity
0.00
52W high / low
₹14,793 / ₹7,414
Sales growth (5Y)
17.22%
EBITDA margin
23.42%
Net profit margin
17.40%
Promoter holding
75.00%
Sales (last year)
₹986 Cr

Elantas Beck India Ltd (EBIL) manufactures specialty insulation and protective materials: wire enamels, varnishes/resins, casting/potting compounds, PCB-protection systems and engineering/construction materials. It has plants at Pimpri and Ankleshwar and is 75%-owned by Germany's ELANTAS GmbH.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Elantas Beck rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Elantas Beck.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Elantas Beck announcements

All announcements →

Financials of Elantas Beck

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Elantas Beck

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +169173163174177191184197206210217215222
Expenses +134138126138139153150162166170169170179
Operating Profit36353736383933354040474543
OPM %21%20%23%20%21%20%18%18%20%19%22%21%20%
Other Income +8151217151712109187143
Interest0000000000000
Depreciation3333334555666
Profit before tax40474749495242404453495340
Tax %26%25%25%25%25%20%25%26%26%26%25%25%23%
Net Profit +30353537374231303339363931
EPS in Rs37.9144.6843.9346.6746.5652.7939.1937.5141.4649.5645.7449.6639.20

Financials of Elantas Beck

Profit & Loss

Annual income statement trend

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Sales +341344365383409394383522645680749848864
Expenses +299282287304344340313444535537604676689
Operating Profit4262797865547078110143144172175
OPM %12%18%22%20%16%14%18%15%17%21%19%20%20%
Other Income +8689311822253253554842
Interest0000000011111
Depreciation56567712121212152122
Profit before tax4562818189648091129184183199195
Tax %30%32%33%32%26%22%23%27%24%25%24%26%
Net Profit +324254556650626798137140148146
EPS in Rs39.8752.6868.7369.4882.9962.5177.9084.36123.34173.19176.04186.41184.16
Dividend Payout %11%9%7%6%5%8%6%6%4%3%4%4%

Financials of Elantas Beck

Balance Sheet

Capital structure and asset base

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Equity Capital888888888888
Reserves1281642142703313764344975917248591,000
Borrowings +000000000000
Other Liabilities +57647070767295114119149148158
Total Liabilities1922362913484154565366187178811,0151,166
Fixed Assets +4545364070110103989899223240
CWIP1051501018191317198
Investments3064109139174160218261356517379592
Other Assets +116126140154171176198240250247395326
Total Assets1922362913484154565366187178811,0151,166

Financials of Elantas Beck

Cash Flows

Operating, investing and financing cash movement

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Cash from Operating Activity +31465651334879298313363127
Cash from Investing Activity +19-42-51-45-32-40-69-33-76-13278-194
Cash from Financing Activity +-51-4-5-5-4-5-4-4-5-5-5-6
Net Cash Flow-2002-346-82-3136-74
Free Cash Flow274051311036633786121-8296
CFO/OP107%107%104%96%80%118%136%60%103%120%71%97%

Financials of Elantas Beck

Ratios

Working capital efficiency and return ratios

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Debtor Days535953707557676158556260
Inventory Days8485100757477899573687871
Days Payable5564737371561038667817661
Cash Conversion Cycle828080717877547064416470
Working Capital Days585555626959465748335656
ROCE %35%40%41%33%23%18%19%17%22%28%23%21%
85out of 100

Momentum score · price trend

85 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+36.2%81%
Last 6 months+36.2%85%
Last 3 months+33.5%94%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Elantas Beck: 0.4 × 81 + 0.4 × 85 + 0.2 × 94 = 85.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF